MIR466

Across TCGA pan-cancer cohorts, MIR466 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR466 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR466 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR466 expression acts as an unfavorable survival marker.

STAD, BLCA, and READ are the cancer types where MIR466 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.052	0.496	<.001	36	view →
BLCA	OS	Tertile	IV	0.290	0.605	.034	18	view →
READ	OS	Tertile	All	0.281	0.822	.016	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR466–STAD (OS)

Open the STAD breakdown →